Covered recipient · General Payments record
ASHLINN R NASEMAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Gerontology
General Payments · PY2022–2024
$1,530.13
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $444.49 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $184.04 | 13 |
| Novo Nordisk AS | $111.91 | 7 |
| Insulet Corporation | $50.53 | 2 |
| DEXCOM, INC. | $36.87 | 2 |
| Xeris Pharmaceuticals, Inc. | $22.10 | 1 |
| Amgen Inc. | $21.43 | 1 |
| CeQur Corporation | $17.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $21.43 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115960675 | CMS |
| CeQur Corporation | $17.61 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099651031 | CMS |
| Dexcom, Inc. | $22.79 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153350684 | CMS |
| Dexcom, Inc. | $14.08 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153350686 | CMS |
| Insulet Corporation | $27.17 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116800636 | CMS |
| Insulet Corporation | $23.36 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116800634 | CMS |
| Lilly USA, LLC | $15.11 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135596162 | CMS |
| Lilly USA, LLC | $17.86 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135565400 | CMS |
| Lilly USA, LLC | $16.73 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135560086 | CMS |
| Lilly USA, LLC | $18.91 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135565402 | CMS |
| Lilly USA, LLC | $4.25 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135560920 | CMS |
| Lilly USA, LLC | $0.84 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135565404 | CMS |
| Lilly USA, LLC | $16.27 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135565406 | CMS |
| Lilly USA, LLC | $7.46 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135581476 | CMS |
| Lilly USA, LLC | $14.11 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135560088 | CMS |
| Lilly USA, LLC | $13.30 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135565408 | CMS |
| Lilly USA, LLC | $22.43 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135581478 | CMS |
| Lilly USA, LLC | $21.02 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135539868 | CMS |
| Lilly USA, LLC | $15.75 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135560922 | CMS |
| Novo Nordisk Inc | $14.57 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100269356 | CMS |
| Novo Nordisk Inc | $15.35 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100289012 | CMS |
| Novo Nordisk Inc | $19.50 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100246423 | CMS |
| Novo Nordisk Inc | $15.60 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100535597 | CMS |
| Novo Nordisk Inc | $16.59 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100638090 | CMS |
| Novo Nordisk Inc | $14.90 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100520635 | CMS |
| Novo Nordisk Inc | $15.40 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100379135 | CMS |
| Xeris Pharmaceuticals, Inc. | $22.10 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144620973 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.